1. Home
  2. FENC vs AMPX Comparison

FENC vs AMPX Comparison

Compare FENC & AMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FENC
  • AMPX
  • Stock Information
  • Founded
  • FENC 1996
  • AMPX 2008
  • Country
  • FENC United States
  • AMPX United States
  • Employees
  • FENC 32
  • AMPX N/A
  • Industry
  • FENC Biotechnology: Biological Products (No Diagnostic Substances)
  • AMPX Industrial Machinery/Components
  • Sector
  • FENC Health Care
  • AMPX Miscellaneous
  • Exchange
  • FENC Nasdaq
  • AMPX Nasdaq
  • Market Cap
  • FENC 222.9M
  • AMPX 261.6M
  • IPO Year
  • FENC 2001
  • AMPX N/A
  • Fundamental
  • Price
  • FENC $8.34
  • AMPX $4.26
  • Analyst Decision
  • FENC Strong Buy
  • AMPX Strong Buy
  • Analyst Count
  • FENC 2
  • AMPX 7
  • Target Price
  • FENC $13.00
  • AMPX $8.71
  • AVG Volume (30 Days)
  • FENC 83.2K
  • AMPX 5.3M
  • Earning Date
  • FENC 08-12-2025
  • AMPX 08-07-2025
  • Dividend Yield
  • FENC N/A
  • AMPX N/A
  • EPS Growth
  • FENC N/A
  • AMPX N/A
  • EPS
  • FENC N/A
  • AMPX N/A
  • Revenue
  • FENC $30,912,000.00
  • AMPX $33,115,000.00
  • Revenue This Year
  • FENC $0.85
  • AMPX $167.22
  • Revenue Next Year
  • FENC $55.16
  • AMPX $208.02
  • P/E Ratio
  • FENC N/A
  • AMPX N/A
  • Revenue Growth
  • FENC N/A
  • AMPX 209.20
  • 52 Week Low
  • FENC $3.96
  • AMPX $0.61
  • 52 Week High
  • FENC $8.72
  • AMPX $4.35
  • Technical
  • Relative Strength Index (RSI)
  • FENC 58.31
  • AMPX 68.55
  • Support Level
  • FENC $7.53
  • AMPX $2.55
  • Resistance Level
  • FENC $8.68
  • AMPX $4.27
  • Average True Range (ATR)
  • FENC 0.49
  • AMPX 0.33
  • MACD
  • FENC -0.04
  • AMPX 0.04
  • Stochastic Oscillator
  • FENC 63.18
  • AMPX 98.18

About FENC Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.

About AMPX Amprius Technologies Inc.

Amprius Technologies Inc is engaged in the production of silicon anodes for high-energy-density lithium-ion batteries. The company develops, manufactures and markets lithium-ion batteries for mobility applications, including the aviation, electric vehicle (EV) and light electric vehicle (LEV) industries. The company's batteries are used for existing and emerging aviation applications, including unmanned aerial systems, such as drones and high-altitude pseudo satellites.

Share on Social Networks: